VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ)
$0.1051 -0.0298 (-22.0904%)
Analysed VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) News Sources
Virax Biolabs Group Limited (VRAX) Upgraded to Buy: Here's Why
15-01-2026
yahoo.com
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement
04-12-2025
yahoo.com
Virax Biolabs Group Limited Announces $5 Million Private Placement
03-12-2025
yahoo.com
BC-Most Active Stocks
03-12-2025
yahoo.com
Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders
03-12-2025
yahoo.com
Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes
03-11-2025
yahoo.com
Virax Biolabs (VRAX) Falls 18% on Lack of Leads
27-08-2025
yahoo.com
Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September
26-08-2025
yahoo.com
EXCLUSIVE: Virax Biolabs Inks Research Pact To Advance Long COVID Diagnostic Studies
26-08-2025
yahoo.com
Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy
29-07-2025
yahoo.com
What is the current price of VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ)?
The current price of VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) is $0.1051.
VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) since the previous trading day is $-0.0298.
VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) since the previous trading day is -22.0904%.
What is the most recent average sentiment score for VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ)?
The most recent average sentiment score for VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ)?
The most recent sentiment for VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) is .
SEC-8K** Filing Available For VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.